Latest stories
Featured
Hikma expands its agreement with AFT Pharmaceuticals for the commercialisation of injectable pain medication Combogesic®...
Press Release, Business Development
12 February 2024
- Hikma R&D - Innovating analytical research: meet Saras Konar Story, Life at Hikma 17 July 2025 Hikma R&D - Innovating analytical research: meet Saras Konar
- Hikma remains a constituent of the FTSE4Good Index Press Release, Corporate 16 July 2025 Hikma remains a constituent of the FTSE4Good Index
- Hikma launches Morphine Sulfate Injection, USP, in a prefilled syringe in the US Press Release, Product 14 July 2025 Hikma launches Morphine Sulfate Injection, USP, in a prefilled syringe in the US
- Notice of results Press Release, Financial Results 09 July 2025 Notice of results
Related content